These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20655069)

  • 1. Re: A multi-institutional evaluation of active surveillance for low risk prostate cancer. S. E. Eggener, A. Mueller, R. K. Berglund, R. Ayyathurai, C. Soloway, M. S. Soloway, R. Abouassaly, E. A. Klein, S. J. Jones, C. Zappavigna, L. Goldenberg, P. T. Scardino, J. A. Eastham and B. Guillonneau J Urol 2009; 181: 1635-1641.
    Ayres BE; Bott SR; Barber NJ; Langley SE; Montgomery BS
    J Urol; 2010 Sep; 184(3):1223-4; author reply 1224. PubMed ID: 20655069
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes: W. T. Lowrance, E. B. Elkin, L. M. Jacks, D. S. Yee, T. L. Jang, V. P. Laudone, B. D. Guillonneau, P. T. Scardino and J. A. Eastham J Urol 2010; 183: 1366-1372.
    See WA
    J Urol; 2010 Oct; 184(4):1573-4; author reply 1574. PubMed ID: 20732691
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1% K. Touijer, F. Rabbani, J. R. Otero, F. P. Secin, J. A. Eastham, P. T. Scardino And B. Guillonneau J Urol 2007; 178: 120-124.
    Joseph JV; Greene T
    J Urol; 2008 Feb; 179(2):789-90. PubMed ID: 18082824
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. A. J. Stephenson, D. P. Wood, M. W. Kattan, E. A. Klein, P. T. Scardino, J. A. Eastham and B. S. Carver j urol 2009; 182: 1357-1363.
    Calışkan S; Kaya C
    J Urol; 2011 Mar; 185(3):1155. PubMed ID: 21256516
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories: E. A. Klein, F. J. Bianco, A. M. Serio, J. A. Eastham, M. W. Kattan, J. E. Pontes, A. J. Vickers and P. T. Scardino J Urol 2008; 179: 2212-2217.
    Sivanandam A; Bhandari M
    J Urol; 2008 Dec; 180(6):2716-7; author reply 2717-8. PubMed ID: 18951589
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies: R. Abouassaly, N. Tan, A. Moussa and J. S. Jones J Urol 2008; 180: 911-914.
    Feldstein MS; Hentz JG
    J Urol; 2009 Apr; 181(4):1960-1; author reply 1961. PubMed ID: 19251278
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Is it necessary to remove the seminal vesicles completely at radical prostatectomy? Decision curve analysis of European Society of Urologic Oncology criteria F. P. Secin, F. J. Bianco, A. Cronin, J. A. Eastham, P. T. Scardino, B. Guillonneau and A. J. Vickers J Urol 2009; 181: 609-614.
    Bellina M; Ambu A; Mari M
    J Urol; 2009 Sep; 182(3):1233. PubMed ID: 19625054
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Prostate cancer severity among low income, uninsured men. D. C. Miller, M. S. Litwin, J. Bergman, S. Stepanian, S. E. Connor, L. Kwan and W. J. Aronson. J Urol 2009; 181: 579-584.
    Watson RA
    J Urol; 2010 Mar; 183(3):1259-60; author reply 1260. PubMed ID: 20097378
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Chemoprevention of prostate cancer. I. M. Thompson, C. M. Tangen, P. J. Goodman, M. S. Lucia and E. A. Klein. J Urol 2009; 182: 499-508.
    Schellhammer PF
    J Urol; 2010 Mar; 183(3):1258-9; author reply 1259. PubMed ID: 20097380
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403.
    Wagner MD; Daneshmand S; Sokoloff M; Barry JM
    J Urol; 2007 Jun; 177(6):2396; author reply 2396-7. PubMed ID: 17509368
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails. A. S. Duffield, T. K. Lee, H. Miyamoto, H. B. Carter and J. I. Epstein. J Urol 2009; 182: 2274-2278.
    Lawrentschuk N; Fleshner NE
    J Urol; 2010 May; 183(5):2099. PubMed ID: 20303514
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Smaller prostate size predicts high grade prostate cancer at final pathology. M. R. Newton, S. Phillips, S. S. Chang, P. E. Clark, M. S. Cookson, R. Davis, J. H. Fowke, S. D. Herrell, R. Baumgartner, R. Chan, V. Mishra, J. D. Blume, J. A. Smith, Jr. and D. A. Barocas. J Urol 2010; 184: 930-937.
    Calışkan S
    J Urol; 2011 Apr; 185(4):1537-8; author reply 1538. PubMed ID: 21349547
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance K. Fujika, P. Landis, B. K. McNeil and C. P. Pavlovich J Urol 2009; 182: 2664-2669.
    Atan A; Tuncel A
    J Urol; 2010 Jun; 183(6):2471-2. PubMed ID: 20416896
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features: R. J. Cohen, B. A. Shannon, M. Phillips, R. E. Moorin, T. M. Wheeler and K. L. Garrett J Urol 2008; 179: 1762-1767.
    Mai KT; Veinot JP
    J Urol; 2008 Dec; 180(6):2714; author reply 214-5. PubMed ID: 18951578
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Genetic polymorphisms of matrix metalloproteinases: susceptibility and prognostic implications for prostate cancer. S. T. dos Reis, J. Pontes, Jr., F. E. Villanova, P. M. D. Borra, A. A. Antunes, M. F. Dall'oglio, M. Srougi and K. R. M. Leite. J Urol 2009; 181: 2320-2325.
    Ahirwar DK; Mittal RD
    J Urol; 2010 Mar; 183(3):1258. PubMed ID: 20097381
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial I. M. Thompson, C. M. Tangen, J. Paradelo, M. S. Lucia, G. Miller, D. Troyer, E. Messing, J. Forman, J. Chin, G. Swanson, E. Canby-Hagino and E. D. Crawford J Urol 2009; 181: 956-962.
    Cheng T; Heng DY; Stewart D
    J Urol; 2009 Nov; 182(5):2531-2; discussion 2532-4. PubMed ID: 19766252
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Validation of the Partin nomogram for prostate cancer in a national sample: J. B. Yu, D. V. Makarov, R. Sharma, R. E. Peschel, A. W. Partin and C. P. Gross J Urol 2010; 183: 105-111.
    Ozcan MF; Akbulut Z; Canda AE; Kilic M; Duran E; Balbay MD
    J Urol; 2010 Oct; 184(4):1571-2; author reply 1572-3. PubMed ID: 20732697
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer CenterS. Carlsson, N. Benfante, R. Alvim, D. D. Sjoberg, A. Vickers, V. E. Reuter, S. W. Fine, H. A. Vargas, M. Wiseman, M. Mamoor, B. Ehdaie, V. Laudone, P. Scardino, J. Eastham and K. Touijer
    Shah N; Ioffe V
    J Urol; 2020 Nov; 204(5):1063-1064. PubMed ID: 32698711
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J. S. Jones, A. Patel, L. Schoenfield, J. C. Rabets, C. D. Zippe and C. Magi-Galluzzi. J Urol, 175: 485-488, 2006.
    Inman BA; Myers RP
    J Urol; 2006 Sep; 176(3):1252-3; author reply 1253. PubMed ID: 16890738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.